{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:16:32Z","timestamp":1775862992179,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:00:00Z","timestamp":1503100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00423-017-1617-2","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T07:05:50Z","timestamp":1503126350000},"page":"1103-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm"],"prefix":"10.1007","volume":"402","author":[{"given":"Joaqu\u00edn","family":"G\u00f3mez-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu","family":"Mihai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,19]]},"reference":[{"issue":"9586","key":"1617_CR1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(07)61213-6","volume":"370","author":"A Sitges-Serra","year":"2007","unstructured":"Sitges-Serra A, Bergenfelz A (2007) Clinical update: sporadic primary hyperparathyroidism. Lancet (London, England) 370(9586):468\u2013470","journal-title":"Lancet (London, England)"},{"issue":"25","key":"1617_CR2","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365(25):2389\u20132397","journal-title":"N Engl J Med"},{"issue":"2","key":"1617_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2):351\u2013365","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1617_CR4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9343(69)90222-8","volume":"47","author":"MR Wills","year":"1969","unstructured":"Wills MR, Pak CY, Hammond WG, Bartter FC (1969) Normocalcemic primary hyperparathyroidism. Am J Med 47(3):384\u2013391","journal-title":"Am J Med"},{"issue":"3","key":"1617_CR5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","volume":"42","author":"A Garcia-Martin","year":"2012","unstructured":"Garcia-Martin A, Reyes-Garcia R, Munoz-Torres M (2012) Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women. Endocrine 42(3):764\u2013766","journal-title":"Endocrine"},{"issue":"3","key":"1617_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","volume":"121","author":"E Lundgren","year":"1997","unstructured":"Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121(3):287\u2013294","journal-title":"Surgery"},{"issue":"5","key":"1617_CR7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","volume":"55","author":"TF Marques","year":"2011","unstructured":"Marques TF, Vasconcelos R, Diniz E, Rego D, Griz L, Bandeira F (2011) Normocalcaemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat? Arq Bras Endocrinol Metabol 55(5):314\u2013317","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"7","key":"1617_CR8","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM et al (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98(7):2734\u20132741","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1617_CR9","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92(8):3001\u20133005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1617_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","volume":"34","author":"MM Tuna","year":"2016","unstructured":"Tuna MM, Caliskan M, Unal M, Demirci T, Dogan BA, Kucukler K et al (2016) Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J Bone Miner Metab 34(3):331\u2013335","journal-title":"J Bone Miner Metab"},{"key":"1617_CR11","doi-asserted-by":"crossref","first-page":"128352","DOI":"10.1155\/2012\/128352","volume":"2012","author":"LM Amaral","year":"2012","unstructured":"Amaral LM, Queiroz DC, Marques TF, Mendes M, Bandeira F (2012) Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone? J Osteoporos 2012:128352","journal-title":"J Osteoporos"},{"issue":"8","key":"1617_CR12","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","volume":"98","author":"E Koumakis","year":"2013","unstructured":"Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E et al (2013) Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab 98(8):3213\u20133220","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1617_CR13","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","volume":"25","author":"E Koumakis","year":"2014","unstructured":"Koumakis E, Souberbielle JC, Payet J, Sarfati E, Borderie D, Kahan A et al (2014) Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism. Osteoporos Int 25(7):1963\u20131968","journal-title":"Osteoporos Int"},{"issue":"11","key":"1617_CR14","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"Silverberg SJ, Bilezikian JP (2003) \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab 88(11):5348\u20135352","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1617_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","volume":"22","author":"H Siprova","year":"2016","unstructured":"Siprova H, Frysak Z, Soucek M (2016) Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract 22(3):294\u2013301","journal-title":"Endocr Pract"},{"issue":"11","key":"1617_CR16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","volume":"117","author":"KM Tordjman","year":"2004","unstructured":"Tordjman KM, Greenman Y, Osher E, Shenkerman G, Stern N (2004) Characterization of normocalcemic primary hyperparathyroidism. Am J Med 117(11):861\u2013863","journal-title":"Am J Med"},{"issue":"2","key":"1617_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","volume":"63","author":"F Yener Ozturk","year":"2016","unstructured":"Yener Ozturk F, Erol S, Canat MM, Karatas S, Kuzu I, Dogan Cakir S et al (2016) Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients. Endocr J 63(2):111\u2013118","journal-title":"Endocr J"},{"issue":"6","key":"1617_CR18","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","volume":"100","author":"G Chen","year":"2015","unstructured":"Chen G, Xue Y, Zhang Q, Xue T, Yao J, Huang H et al (2015) Is normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab 100(6):2420\u20132424","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1617_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP (2013) Normocalcemic primary hyperparathyroidism. J Clin Densitom 16(1):33\u201339","journal-title":"J Clin Densitom"},{"issue":"10","key":"1617_CR20","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561\u20133569","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1617_CR21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","volume":"67","author":"DS Rao","year":"1988","unstructured":"Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67(6):1294\u20131298","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1617_CR22","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani G, Hertig A, Paillard M, Houillier P (2003) Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 88(10):4641\u20134648","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1617_CR23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/BF03346429","volume":"31","author":"JA Balsa","year":"2008","unstructured":"Balsa JA, Botella-Carretero JI, Peromingo R, Zamarron I, Arrieta F, Munoz-Malo T et al (2008) Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion. J Endocrinol Investig 31(10):845\u2013850","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"1617_CR24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/jbmr.1999.14.4.652","volume":"14","author":"PL Selby","year":"1999","unstructured":"Selby PL, Davies M, Adams JE, Mawer EB (1999) Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res Off J Am Soc Bone Miner Res 14(4):652\u2013657","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"1","key":"1617_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00268-016-3716-6","volume":"41","author":"OA Lavryk","year":"2017","unstructured":"Lavryk OA, Siperstein AE (2017) Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients. World J Surg 41(1):122\u2013128","journal-title":"World J Surg"},{"issue":"10","key":"1617_CR26","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3570\u20133579","journal-title":"J Clin Endocrinol Metab"},{"issue":"10\u201311","key":"1617_CR27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.clinbiochem.2011.04.002","volume":"44","author":"E Nordenstrom","year":"2011","unstructured":"Nordenstrom E, Katzman P, Bergenfelz A (2011) Biochemical diagnosis of primary hyperparathyroidism: analysis of the sensitivity of total and ionized calcium in combination with PTH. Clin Biochem 44(10\u201311):849\u2013852","journal-title":"Clin Biochem"},{"issue":"9","key":"1617_CR28","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","volume":"97","author":"GS Ong","year":"2012","unstructured":"Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL et al (2012) The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab 97(9):3138\u20133145","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1617_CR29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","volume":"36","author":"TJ Wade","year":"2012","unstructured":"Wade TJ, Yen TW, Amin AL, Wang TS (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36(4):761\u2013766","journal-title":"World J Surg"},{"issue":"7","key":"1617_CR30","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"1617_CR31","first-page":"S1","volume":"113","author":"KDIGO","year":"2009","unstructured":"KDIGO (2009) Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013130","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"1617_CR32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI107156","volume":"52","author":"FL Coe","year":"1973","unstructured":"Coe FL, Canterbury JM, Firpo JJ, Reiss E (1973) Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 52(1):134\u2013142","journal-title":"J Clin Invest"},{"issue":"2","key":"1617_CR33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ando.2015.03.005","volume":"76","author":"JC Souberbielle","year":"2015","unstructured":"Souberbielle JC, Cavalier E, Cormier C (2015) How to manage an isolated elevated PTH? Ann Endocrinol 76(2):134\u2013141","journal-title":"Ann Endocrinol"},{"issue":"6","key":"1617_CR34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.surg.2007.07.023","volume":"142","author":"DM Carneiro-Pla","year":"2007","unstructured":"Carneiro-Pla DM, Irvin GL 3rd, Chen H (2007) Consequences of parathyroidectomy in patients with \u201cmild\u201d sporadic primary hyperparathyroidism. Surgery 142(6):795\u2013799 discussion 9.e1\u20132","journal-title":"Surgery"},{"issue":"1","key":"1617_CR35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.surg.2016.08.054","volume":"161","author":"JY Lim","year":"2017","unstructured":"Lim JY, Herman MC, Bubis L, Epelboym I, Allendorf JD, Chabot JA et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161(1):70\u201377","journal-title":"Surgery"},{"issue":"6","key":"1617_CR36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.surg.2011.09.017","volume":"150","author":"M Goldfarb","year":"2011","unstructured":"Goldfarb M, Gondek S, Irvin GL 3rd, Lew JI (2011) Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years. Surgery 150(6):1076\u20131084","journal-title":"Surgery"},{"issue":"4","key":"1617_CR37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.surg.2012.07.005","volume":"152","author":"CB Carsello","year":"2012","unstructured":"Carsello CB, Yen TW, Wang TS (2012) Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter? Surgery 152(4):575\u2013581 discussion 81\u20133","journal-title":"Surgery"},{"issue":"5","key":"1617_CR38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjsurg.2014.01.005","volume":"207","author":"HC Stuart","year":"2014","unstructured":"Stuart HC, Harvey A, Pasieka JL (2014) Normocalcemic hyperparathyroidism: preoperatively a disease, postoperatively cured? Am J Surg 207(5):673\u2013680 discussion 80\u20131","journal-title":"Am J Surg"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-017-1617-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-017-1617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-017-1617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T05:19:15Z","timestamp":1509167955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-017-1617-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,19]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1007\/s00423-017-1617-2","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,19]]}}}